ASCO: Time to Change Lung Ca Surrogate Endpoint?

CHICAGO (MedPage Today) -- An FDA meta-analysis supported response rate as a surrogate endpoint in metastatic non-small cell lung cancer, but others said it?s time to look beyond conventional measures. via MedPageToday.com - medical news plus CME for physicians Read More Here..

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://ift.tt/1m3glM8